HEATHER YOST: Open Payments
NPI 1700038700 · WATSONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 152 payments from 20 companies in 2025. Trend: 2023 $2,359 · 2024 $2,675 · 2025 $2,753
Food & beverage: $2,753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 35 | $590 |
| ABBVIE INC. | 30 | $514 |
| Lilly USA, LLC | 15 | $290 |
| PFIZER INC. | 12 | $193 |
| AstraZeneca Pharmaceuticals LP | 8 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $157 |
| Amgen Inc. | 10 | $154 |
| Exact Sciences Corporation | 7 | $152 |
| GlaxoSmithKline, LLC. | 8 | $143 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
Products named: Ozempic, VRAYLAR, QULIPTA, CAPLYTA, Wegovy, UBRELVY, JARDIANCE, MOUNJARO.
Industry payments across PA — which companies pay providers there.
